CompletedNCT02497287
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Medication studyAges 18+Multiple countries
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- New Haven and 108 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: September 30, 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 802
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Australia, France, ...
- Age range
- Over 18 Years
- Official registry ID
- NCT02497287
- Official title
Show the full official title
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Recruitment & locations
CompletedNew Haven, United States · Miami, United States · Marietta, United States
107 more locations
- Iowa City, United States
- Wichita, United States
- Baltimore, United States
- Watertown, United States
- Cedarhurst, United States
- New York, United States
- Staten Island, United States
- Cincinnati, United States
- Allentown, United States
- Charleston, United States
- Dallas, United States
- Wichita Falls, United States
- Richland, United States
- Banfield, Argentina
- Buenos Aires, Argentina
- Córdoba, Argentina
- La Plata, Argentina
- Mendoza, Argentina
- Rosario, Argentina
- Adelaide, Australia
- Caulfield, Australia
- Frankston, Australia
- Melbourne, Australia
- Innsbruck, Austria
- Vienna, Austria
- Bruges, Belgium
- Hasselt, Belgium
- Belo Horizonte, Brazil
- Fortaleza, Brazil
- Recife, Brazil
- Rio de Janeiro, Brazil
- Santo André, Brazil
- São José do Rio Preto, Brazil
- São Paulo, Brazil
- Burgas, Bulgaria
- Kardzhali, Bulgaria
- Kazanlak, Bulgaria
- Pazardzhik, Bulgaria
- Pleven, Bulgaria
- Plovdiv, Bulgaria
- Rousse, Bulgaria
- Sofia, Bulgaria
- Varna, Bulgaria
- Helsinki, Finland
- Kuopio, Finland
- Paris, France
- Poitiers, France
- Toulon, France
- Tours, France
- Berlin, Germany
- Bochum, Germany
- Oranienburg-Sachsenhausen, Germany
- Kaunas, Lithuania
- Šilutė, Lithuania
- Vilnius, Lithuania
- Ipoh, Malaysia
- Johor Bahru, Malaysia
- Kuala Lumpur, Malaysia
- Acapulco, Mexico
- Durango, Mexico
- Mexico City, Mexico
- México, Mexico
- Monterrey, Mexico
- Gdansk, Poland
- Cape Town, South Africa
- Garsfontein, South Africa
- Pretoria, South Africa
- Gwangju, South Korea
- Gyeonggi-do, South Korea
- Seoul, South Korea
- Badajoz, Spain
- Bilbao, Spain
- Madrid, Spain
- Ourense, Spain
- Oviedo, Spain
- Sant Boi de Llobregat, Spain
- Torrevieja, Spain
- Valencia, Spain
- Zamora, Spain
- Gothenburg, Sweden
- Halmstad, Sweden
- Lund, Sweden
- Skövde, Sweden
- Solna, Sweden
- Stockholm, Sweden
- Umeå, Sweden
- Kaohsiung City, Taiwan
- New Taipei City, Taiwan
- Taichung, Taiwan
- Tainan, Taiwan
- Taipei, Taiwan
- Taoyuan County, Taiwan
- Ankara, Türkiye
- Bursa, Türkiye
- Gaziantep, Türkiye
- Istanbul, Türkiye
- Kocaeli, Türkiye
- Manisa, Türkiye
- Bristol, United Kingdom
- Chesterfield, United Kingdom
- Derby, United Kingdom
- London, United Kingdom
- Middlesbrough, United Kingdom
- Northampton, United Kingdom
- Oxford, United Kingdom
- Preston, United Kingdom
- Türkiye
Questions about this study
Who is behind this study?
The study sponsor is Janssen Research & Development, LLC.
Did this study involve medication?
Yes. The study involved medication, including Esketamine (Intranasal Spray), Duloxetine (Oral Antidepressant), Escitalopram (Oral Antidepressant), Sertraline (Oral Antidepressant) and Venlafaxine Extended Release (XR) (Oral Antidepressant).
Who was this study for?
Listed age limits: from 18 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me